查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2132248

個人化診斷市場規模、佔有率和趨勢分析報告：按測試類型、技術、應用、最終用途、地區和細分市場預測（2026-2033 年）

Personalized Diagnostics Market Size, Share & Trends Analysis Report By Testing Type, By Technology, By Application, By End-use, By Region, And Segment Forecasts, 2026 - 2033
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

個性化診斷市場概覽

全球個人化診斷市場預計到 2025 年將達到 121 億美元，從 2026 年的 134 億美元成長到 2033 年的 300 億美元，2026 年至 2033 年的複合年成長率將達到 12.2%。

到2025年，北美將引領市場，佔全球銷售額的39.9%。該市場正經歷強勁成長，這主要得益於精準醫療的日益普及、基因組和分子診斷技術的進步，以及對基於生物標記的檢測（可實現個人化治療決策）日益成長的需求。

此外，伴隨診斷的日益普及、癌症和遺傳疾病的日益流行以及對精準醫療投資的增加，預計將在預測期內進一步加速市場成長。

目錄

第1章：調查方法和範圍

第2章執行摘要

第3章 市場：變數、趨勢與範圍

  • 市場區隔和範圍
  • 市場譜系展望
  • 市場趨勢/前景
  • 市場促進因素
  • 市場限制因素分析
  • 按測試類型分類的分析工具

第4章：依測試類型進行業務分析

  • 基因和營養基因組學檢測
  • 微生物組檢測
  • 代謝健康測試
  • 微量營養素缺乏症檢測
  • 食物敏感性和不耐受性測試
  • 荷爾蒙健康測試
  • 預防性健康與長壽篩檢
  • 其他

第5章：依技術進行業務分析

  • 個性化診斷市場：按技術分類的趨勢分析
  • 下一代定序（NGS）
  • 免疫測量
  • 聚合酵素鏈鎖反應（PCR）
  • 質譜分析
  • 微陣列技術
  • 其他

第6章 應用業務分析

  • 個人化診斷市場：按應用領域分類的趨勢分析
  • 個人化營養
  • 預防性健康檢查
  • 體重管理
  • 健康老化和長壽
  • 慢性病風險評估
  • 腸道環境和微生物組分析
  • 最佳化健身和生活方式
  • 藥物基因體學

第7章 依最終用途進行業務分析

  • 個人化診斷市場：依最終用途分類的趨勢分析
  • 直接面對消費者銷售（DTC）
  • 診斷實驗室
  • 健康與營養相關企業
  • 醫院和診所
  • 其他

第8章：區域商業分析

  • 個人化診斷市場佔有率：按地區分類，2022 年和 2033 年
  • 北美洲
    • SWOT分析
    • 2021-2033年北美個人化診斷市場
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • SWOT分析
    • 歐洲個人化診斷市場，2021-2033年
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • SWOT分析
    • 亞太地區個人化診斷市場，2021-2033年
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 泰國
    • 韓國
  • 拉丁美洲
    • SWOT分析
    • 2021-2033年拉丁美洲個人化診斷市場
    • 巴西
    • 阿根廷
  • 中東和非洲
    • SWOT分析
    • 2021-2033年中東及非洲個人化診斷市場
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第9章 競爭情勢

  • 公司分類
  • 策略規劃
  • 企業市場占有率分析，2025 年
  • 公司簡介
  • Thermo Fisher Scientific, Inc.
    • 概述
    • 財務績效（淨銷售額/銷售額/EBITDA/毛利）
    • 依測試類型進行基準測試
    • 策略舉措
  • Illumina, Inc.
    • 概述
    • 財務績效（淨銷售額/銷售額/EBITDA/毛利）
    • 依測試類型進行基準測試
    • 策略舉措
  • QIAGEN
    • 概述
    • 財務績效（淨銷售額/銷售額/EBITDA/毛利）
    • 依測試類型進行基準測試
    • 策略舉措
  • F. Hoffmann-La Roche Ltd.
    • 概述
    • 財務績效（淨銷售額/銷售額/EBITDA/毛利）
    • 依測試類型進行基準測試
    • 策略舉措
  • Bio-Rad Laboratories Inc.
    • 概述
    • 財務績效（淨銷售額/銷售額/EBITDA/毛利）
    • 依測試類型進行基準測試
    • 策略舉措
  • Agilent Technologies
    • 概述
    • 財務績效（淨銷售額/銷售額/EBITDA/毛利）
    • 依測試類型進行基準測試
    • 策略舉措
  • Exact Sciences Corporation
    • 概述
    • 財務績效（淨銷售額/銷售額/EBITDA/毛利）
    • 依測試類型進行基準測試
    • 策略舉措
  • Guardant Health, Inc.
    • 概述
    • 財務績效（淨銷售額/銷售額/EBITDA/毛利）
    • 依測試類型進行基準測試
    • 策略舉措
  • Danaher Corporation
    • 概述
    • 財務績效（淨銷售額/銷售額/EBITDA/毛利）
    • 依測試類型進行基準測試
    • 策略舉措
  • Abbott
    • 概述
    • 財務績效（淨銷售額/銷售額/EBITDA/毛利）
    • 依測試類型進行基準測試
    • 策略舉措
Product Code: GVR-4-68040-942-2

Personalized Diagnostics Market Summary

The global personalized diagnostics market size was valued at USD 12.1 billion in 2025 and is projected to grow from USD 13.4 billion in 2026 to USD 30.0 billion by 2033, at a CAGR of 12.2% from 2026 to 2033. North America dominated the market with the largest revenue share of 39.9% in 2025. The market is witnessing robust growth due to the increasing adoption of precision medicine, advancements in genomic and molecular diagnostic technologies, and the rising demand for biomarker-based testing to enable personalized treatment decisions.

Furthermore, the expanding use of companion diagnostics, growing prevalence of cancer and genetic disorders, and increasing investments in precision healthcare are expected to further accelerate market growth during the forecast period.

Global Personalized Diagnostics Market Report Segmentation

This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this report, Grand View Research has segmented the global personalized diagnostics market report based on testing type, application, technology, end-use, and region:

  • Testing Type Scope Outlook (Revenue, USD Million, 2021 - 2033)
  • Genetic & Nutrigenomic Testing
  • Microbiome Testing
  • Metabolic Health Testing
  • Micronutrient & Deficiency Testing
  • Food Sensitivity & Intolerance Testing
  • Hormone Health Testing
  • Preventive Wellness & Longevity Testing
    • Epigenetic Age Testing
    • Telomere Length Analysis
    • Proteomics-based Aging Biomarkers
    • Others
  • Others
  • Technology Scope Outlook (Revenue, USD Million, 2021 - 2033)
  • Next-Generation Sequencing (NGS)
  • Immunoassays
  • Polymerase Chain Reaction (PCR)
  • Mass Spectrometry
  • Microarray Technology
  • Others
  • Application Outlook (Revenue, USD Million, 2021 - 2033)
  • Personalized Nutrition
  • Preventive Health Screening
  • Weight Management
  • Healthy Aging & Longevity
  • Chronic Disease Risk Assessment
  • Gut Health & Microbiome Analysis
  • Fitness & Lifestyle Optimization
  • Pharmacogenomics
  • Others
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • Direct-to-Consumer (DTC)
  • Diagnostic Laboratories
  • Wellness & Nutrition Companies
  • Hospitals & Clinics
  • Others
  • Regional Scope Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • Thailand
    • South Korea
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
    • 1.1.1. Segment Definitions
      • 1.1.1.1. Testing Type Segment
      • 1.1.1.2. Technology Segment
      • 1.1.1.3. Application Segment
      • 1.1.1.4. End Use Segment
  • 1.2. Regional Scope
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Objective
    • 1.4.1. Objective 1
    • 1.4.2. Objective2
    • 1.4.3. Objective 3
  • 1.5. Research Methodology
  • 1.6. Information Procurement
    • 1.6.1. Purchased Database
    • 1.6.2. GVR's Internal Database
    • 1.6.3. Secondary Sources
    • 1.6.4. Primary Research
  • 1.7. Information or Data Analysis:
    • 1.7.1. Data Analysis Models
  • 1.8. Market Formulation & Validation
  • 1.9. Model Details
    • 1.9.1. Commodity Flow Analysis
  • 1.10. List of Secondary Sources
  • 1.11. List of Abbreviations

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Segmentation and Scope
  • 3.2. Market Lineage Outlook
    • 3.2.1. Parent Market Outlook
    • 3.2.2. Related/Ancillary Market Outlook
  • 3.3. Market Trends and Outlook
  • 3.4. Market Drivers
    • 3.4.1. Growing Adoption of Precision Medicine and Biomarker-Guided Therapies
    • 3.4.2. Advancements in Genomic Technologies and Next-Generation Sequencing (NGS)
    • 3.4.3. Rising Demand for Early Disease Detection and Personalized Healthcare Solutions
  • 3.5. Market Restraint Analysis
    • 3.5.1. Stringent regulatory guidelines
  • 3.6. Testing Type Analysis Tools
    • 3.6.1. Porter's Five Forces Analysis
    • 3.6.2. PESTEL Analysis

Chapter 4. Testing Type Business Analysis

  • 4.1. Genetic & Nutrigenomic Testing
    • 4.1.1. Genetic & Nutrigenomic Testing Market, 2021 - 2033 (USD Million)
  • 4.2. Microbiome Testing
    • 4.2.1. Microbiome Testing Market, 2021 - 2033 (USD Million)
  • 4.3. Metabolic Health Testing
    • 4.3.1. Metabolic Health Testing Market, 2021 - 2033 (USD Million)
  • 4.4. Micronutrient & Deficiency Testing
    • 4.4.1. Micronutrient & Deficiency Testing Market, 2021 - 2033 (USD Million)
  • 4.5. Food Sensitivity & Intolerance Testing
    • 4.5.1. Food Sensitivity & Intolerance Testing Market, 2021 - 2033 (USD Million)
  • 4.6. Hormone Health Testing
    • 4.6.1. Hormone Health Testing Market, 2021 - 2033 (USD Million)
  • 4.7. Preventive Wellness & Longevity Testing
    • 4.7.1. Preventive Wellness & Longevity Testing Market, 2021 - 2033 (USD Million)
      • 4.7.1.1. Preventive Wellness & Longevity Testing Market, 2021 - 2033 (USD Million)
    • 4.7.2. Epigenetic Age Testing
      • 4.7.2.1. Epigenetic Age Testing Market, 2021 - 2033 (USD Million)
    • 4.7.3. Telomere Length Analysis
      • 4.7.3.1. Telomere Length Analysis Market, 2021 - 2033 (USD Million)
    • 4.7.4. Proteomics-based Aging Biomarkers
      • 4.7.4.1. Proteomics-based Aging Biomarkers Market, 2021 - 2033 (USD Million)
    • 4.7.5. Others
      • 4.7.5.1. Others Market, 2021 - 2033 (USD Million)
  • 4.8. Others
    • 4.8.1. Others Market: Testing Type Movement Analysis

Chapter 5. Technology Business Analysis

  • 5.1. Personalized Diagnostics Market: Technology Movement Analysis
  • 5.2. Next-Generation Sequencing (NGS)
    • 5.2.1. Next-Generation Sequencing (NGS) Market, 2021 - 2033 (USD Million)
  • 5.3. Immunoassays
    • 5.3.1. Immunoassays Market, 2021 - 2033 (USD Million)
  • 5.4. Polymerase Chain Reaction (PCR)
    • 5.4.1. Polymerase Chain Reaction (PCR) Market, 2021 - 2033 (USD Million)
  • 5.5. Mass Spectrometry
    • 5.5.1. Mass Spectrometry Market, 2021 - 2033 (USD Million)
  • 5.6. Microarray Technology
    • 5.6.1. Microarray Technology Market, 2021 - 2033 (USD Million)
  • 5.7. Others
    • 5.7.1. Others Market, 2021 - 2033 (USD Million)

Chapter 6. Application Business Analysis

  • 6.1. Personalized Diagnostics Market: Application Movement Analysis
  • 6.2. Personalized Nutrition
    • 6.2.1. Microarray Technology Market, 2021 - 2033 (USD Million)
  • 6.3. Preventive Health Screening
    • 6.3.1. Microarray Technology Market, 2021 - 2033 (USD Million)
  • 6.4. Weight Management
    • 6.4.1. Microarray Technology Market, 2021 - 2033 (USD Million)
  • 6.5. Healthy Aging & Longevity
    • 6.5.1. Microarray Technology Market, 2021 - 2033 (USD Million)
  • 6.6. Chronic Disease Risk Assessment
    • 6.6.1. Microarray Technology Market, 2021 - 2033 (USD Million)
  • 6.7. Gut Health & Microbiome Analysis
    • 6.7.1. Microarray Technology Market, 2021 - 2033 (USD Million)
  • 6.8. Fitness & Lifestyle Optimization
    • 6.8.1. Microarray Technology Market, 2021 - 2033 (USD Million)
  • 6.9. Pharmacogenomics
    • 6.9.1. Microarray Technology Market, 2021 - 2033 (USD Million)

Chapter 7. End Use Business Analysis

  • 7.1. Personalized Diagnostics Market: End Use Movement Analysis
  • 7.2. Direct-to-Consumer (DTC)
    • 7.2.1. Direct-to-Consumer (DTC) Market, 2021 - 2033 (USD Million)
  • 7.3. Diagnostic Laboratories
    • 7.3.1. Diagnostic Laboratories Market, 2021 - 2033 (USD Million)
  • 7.4. Wellness & Nutrition Companies
    • 7.4.1. Wellness & Nutrition Companies Market, 2021 - 2033 (USD Million)
  • 7.5. Hospitals & Clinics
    • 7.5.1. Hospitals & Clinics Market, 2021 - 2033 (USD Million)
  • 7.6. Others
    • 7.6.1. Others Market, 2021 - 2033 (USD Million)

Chapter 8. Regional Business Analysis

  • 8.1. Personalized Diagnostics Market Share By Region, 2022 & 2033
  • 8.2. North America
    • 8.2.1. SWOT Analysis
    • 8.2.2. North America Personalized Diagnostics Market, 2021 - 2033 (USD Million)
    • 8.2.3. U.S.
      • 8.2.3.1. Key Country Dynamics
      • 8.2.3.2. Competitive Scenario
      • 8.2.3.3. Regulatory Framework
      • 8.2.3.4. U.S. Personalized Diagnostics Market, 2021 - 2033 (USD Million)
    • 8.2.4. Canada
      • 8.2.4.1. Key Country Dynamics
      • 8.2.4.2. Competitive Scenario
      • 8.2.4.3. Regulatory Framework
      • 8.2.4.4. Canada Personalized Diagnostics Market, 2021 - 2033 (USD Million)
    • 8.2.5. Mexico
      • 8.2.5.1. Key Country Dynamics
      • 8.2.5.2. Competitive Scenario
      • 8.2.5.3. Regulatory Framework
      • 8.2.5.4. Mexico Personalized Diagnostics Market, 2021 - 2033 (USD Million)
  • 8.3. Europe
    • 8.3.1. SWOT Analysis
    • 8.3.2. Europe Personalized Diagnostics Market, 2021 - 2033 (USD Million)
    • 8.3.3. UK
      • 8.3.3.1. Key Country Dynamics
      • 8.3.3.2. Competitive Scenario
      • 8.3.3.3. Regulatory Framework
      • 8.3.3.4. UK Personalized Diagnostics Market, 2021 - 2033 (USD Million)
    • 8.3.4. Germany
      • 8.3.4.1. Key Country Dynamics
      • 8.3.4.2. Competitive Scenario
      • 8.3.4.3. Regulatory Framework
      • 8.3.4.4. Germany Personalized Diagnostics Market, 2021 - 2033 (USD Million)
    • 8.3.5. France
      • 8.3.5.1. Key Country Dynamics
      • 8.3.5.2. Competitive Scenario
      • 8.3.5.3. Regulatory Framework
      • 8.3.5.4. France Personalized Diagnostics Market, 2021 - 2033 (USD Million)
    • 8.3.6. Italy
      • 8.3.6.1. Key Country Dynamics
      • 8.3.6.2. Competitive Scenario
      • 8.3.6.3. Regulatory Framework
      • 8.3.6.4. Italy Personalized Diagnostics Market, 2021 - 2033 (USD Million)
    • 8.3.7. Spain
      • 8.3.7.1. Key Country Dynamics
      • 8.3.7.2. Competitive Scenario
      • 8.3.7.3. Regulatory Framework
      • 8.3.7.4. Spain Personalized Diagnostics Market, 2021 - 2033 (USD Million)
    • 8.3.8. Denmark
      • 8.3.8.1. Key Country Dynamics
      • 8.3.8.2. Competitive Scenario
      • 8.3.8.3. Regulatory Framework
      • 8.3.8.4. Denmark Personalized Diagnostics Market, 2021 - 2033 (USD Million)
    • 8.3.9. Sweden
      • 8.3.9.1. Key Country Dynamics
      • 8.3.9.2. Competitive Scenario
      • 8.3.9.3. Regulatory Framework
      • 8.3.9.4. Sweden Personalized Diagnostics Market, 2021 - 2033 (USD Million)
    • 8.3.10. Norway
      • 8.3.10.1. Key Country Dynamics
      • 8.3.10.2. Competitive Scenario
      • 8.3.10.3. Regulatory Framework
      • 8.3.10.4. Norway Personalized Diagnostics Market, 2021 - 2033 (USD Million)
  • 8.4. Asia Pacific
    • 8.4.1. SWOT Analysis
    • 8.4.2. Asia Pacific Personalized Diagnostics Market, 2021 - 2033 (USD Million)
    • 8.4.3. Japan
      • 8.4.3.1. Key Country Dynamics
      • 8.4.3.2. Competitive Scenario
      • 8.4.3.3. Regulatory Framework
      • 8.4.3.4. Japan Personalized Diagnostics Market, 2021 - 2033 (USD Million)
    • 8.4.4. China
      • 8.4.4.1. Key Country Dynamics
      • 8.4.4.2. Competitive Scenario
      • 8.4.4.3. Regulatory Framework
      • 8.4.4.4. China Personalized Diagnostics Market, 2021 - 2033 (USD Million)
    • 8.4.5. India
      • 8.4.5.1. Key Country Dynamics
      • 8.4.5.2. Competitive Scenario
      • 8.4.5.3. Regulatory Framework
      • 8.4.5.4. India Personalized Diagnostics Market, 2021 - 2033 (USD Million)
    • 8.4.6. Australia
      • 8.4.6.1. Key Country Dynamics
      • 8.4.6.2. Competitive Scenario
      • 8.4.6.3. Regulatory Framework
      • 8.4.6.4. Australia Personalized Diagnostics Market, 2021 - 2033 (USD Million)
    • 8.4.7. Thailand
      • 8.4.7.1. Key Country Dynamics
      • 8.4.7.2. Competitive Scenario
      • 8.4.7.3. Regulatory Framework
      • 8.4.7.4. Thailand Personalized Diagnostics Market, 2021 - 2033 (USD Million)
    • 8.4.8. South Korea
      • 8.4.8.1. Key Country Dynamics
      • 8.4.8.2. Competitive Scenario
      • 8.4.8.3. Regulatory Framework
      • 8.4.8.4. South Korea Personalized Diagnostics Market, 2021 - 2033 (USD Million)
  • 8.5. Latin America
    • 8.5.1. SWOT Analysis
    • 8.5.2. Latin America Personalized Diagnostics Market, 2021 - 2033 (USD Million)
    • 8.5.3. Brazil
      • 8.5.3.1. Key Country Dynamics
      • 8.5.3.2. Competitive Scenario
      • 8.5.3.3. Regulatory Framework
      • 8.5.3.4. Brazil Personalized Diagnostics Market, 2021 - 2033 (USD Million)
    • 8.5.4. Argentina
      • 8.5.4.1. Key Country Dynamics
      • 8.5.4.2. Competitive Scenario
      • 8.5.4.3. Regulatory Framework
      • 8.5.4.4. Argentina Personalized Diagnostics Market, 2021 - 2033 (USD Million)
  • 8.6. MEA
    • 8.6.1. SWOT Analysis
    • 8.6.2. MEA Personalized Diagnostics Market, 2021 - 2033 (USD Million)
    • 8.6.3. South Africa
      • 8.6.3.1. Key Country Dynamics
      • 8.6.3.2. Competitive Scenario
      • 8.6.3.3. Regulatory Framework
      • 8.6.3.4. South Africa Personalized Diagnostics Market, 2021 - 2033 (USD Million)
    • 8.6.4. Saudi Arabia
      • 8.6.4.1. Key Country Dynamics
      • 8.6.4.2. Competitive Scenario
      • 8.6.4.3. Regulatory Framework
      • 8.6.4.4. Saudi Arabia Personalized Diagnostics Market, 2021 - 2033 (USD Million)
    • 8.6.5. UAE
      • 8.6.5.1. Key Country Dynamics
      • 8.6.5.2. Competitive Scenario
      • 8.6.5.3. Regulatory Framework
      • 8.6.5.4. UAE Personalized Diagnostics Market, 2021 - 2033 (USD Million)
    • 8.6.6. Kuwait
      • 8.6.6.1. Key Country Dynamics
      • 8.6.6.2. Competitive Scenario
      • 8.6.6.3. Regulatory Framework
      • 8.6.6.4. Kuwait Personalized Diagnostics Market, 2021 - 2033 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Company Categorization
  • 9.2. Strategy Mapping
  • 9.3. Company Market Share Analysis, 2025
  • 9.4. Company Profiles
  • 9.5. Thermo Fisher Scientific, Inc.
    • 9.5.1. Overview
    • 9.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 9.5.3. Testing Type Benchmarking
    • 9.5.4. Strategic Initiatives
  • 9.6. Illumina, Inc.
    • 9.6.1. Overview
    • 9.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 9.6.3. Testing Type Benchmarking
    • 9.6.4. Strategic Initiatives
  • 9.7. QIAGEN
    • 9.7.1. Overview
    • 9.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 9.7.3. Testing Type Benchmarking
    • 9.7.4. Strategic Initiatives
  • 9.8. F. Hoffmann-La Roche Ltd.
    • 9.8.1. Overview
    • 9.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 9.8.3. Testing Type Benchmarking
    • 9.8.4. Strategic Initiatives
  • 9.9. Bio-Rad Laboratories Inc.
    • 9.9.1. Overview
    • 9.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 9.9.3. Testing Type Benchmarking
    • 9.9.4. Strategic Initiatives
  • 9.10. Agilent Technologies
    • 9.10.1. Overview
    • 9.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 9.10.3. Testing Type Benchmarking
    • 9.10.4. Strategic Initiatives
  • 9.11. Exact Sciences Corporation
    • 9.11.1. Overview
    • 9.11.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 9.11.3. Testing Type Benchmarking
    • 9.11.4. Strategic Initiatives
  • 9.12. Guardant Health, Inc.
    • 9.12.1. Overview
    • 9.12.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 9.12.3. Testing Type Benchmarking
    • 9.12.4. Strategic Initiatives
  • 9.13. Danaher Corporation
    • 9.13.1. Overview
    • 9.13.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 9.13.3. Testing Type Benchmarking
    • 9.13.4. Strategic Initiatives
  • 9.14. Abbott
    • 9.14.1. Overview
    • 9.14.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 9.14.3. Testing Type Benchmarking
    • 9.14.4. Strategic Initiatives

List of Tables

  • Table 1. List of abbreviations
  • Table 2. Global Personalized Diagnostics Market, by Testing Type, 2021 - 2033 (USD Million)
  • Table 3. Global Personalized Diagnostics Market, by Technology, 2021 - 2033 (USD Million)
  • Table 4. Global Personalized Diagnostics Market, by Application, 2021 - 2033 (USD Million)
  • Table 5. Global Personalized Diagnostics Market, by region, 2021 - 2033 (USD Million)
  • Table 6. North America Personalized Diagnostics Market, by country, 2021 - 2033 (USD Million)
  • Table 7. North America Personalized Diagnostics Market, by Testing Type, 2021 - 2033 (USD Million)
  • Table 8. North America Personalized Diagnostics Market, by Technology, 2021 - 2033 (USD Million)
  • Table 9. North America Personalized Diagnostics Market, by Application, 2021 - 2033 (USD Million)
  • Table 10. U.S. Personalized Diagnostics Market, by Testing Type, 2021 - 2033 (USD Million)
  • Table 11. U.S. Personalized Diagnostics Market, by Technology, 2021 - 2033 (USD Million)
  • Table 12. U.S. Personalized Diagnostics Market, by Application, 2021 - 2033 (USD Million)
  • Table 13. Canada Personalized Diagnostics Market, by Testing Type, 2021 - 2033 (USD Million)
  • Table 14. Canada Personalized Diagnostics Market, by Technology, 2021 - 2033 (USD Million)
  • Table 15. Canada Personalized Diagnostics Market, by Application, 2021 - 2033 (USD Million)
  • Table 16. Mexico Personalized Diagnostics Market, by Testing Type, 2021 - 2033 (USD Million)
  • Table 17. Mexico Personalized Diagnostics Market, by Technology, 2021 - 2033 (USD Million)
  • Table 18. Mexico Personalized Diagnostics Market, by Application, 2021 - 2033 (USD Million)
  • Table 19. Europe Personalized Diagnostics Market, by country, 2021 - 2033 (USD Million)
  • Table 20. Europe Personalized Diagnostics Market, by Testing Type, 2021 - 2033 (USD Million)
  • Table 21. Europe America Personalized Diagnostics Market, by Technology, 2021 - 2033 (USD Million)
  • Table 22. Europe America Personalized Diagnostics Market, by Application, 2021 - 2033 (USD Million)
  • Table 23. UK Personalized Diagnostics Market, by Testing Type, 2021 - 2033 (USD Million)
  • Table 24. UK Personalized Diagnostics Market, by Technology, 2021 - 2033 (USD Million)
  • Table 25. UK Personalized Diagnostics Market, by drug type, 2021 - 2033 (USD Million)
  • Table 26. Germany Personalized Diagnostics Market, by Testing Type, 2021 - 2033 (USD Million)
  • Table 27. Germany Personalized Diagnostics Market, by Technology, 2021 - 2033 (USD Million)
  • Table 28. Germany Personalized Diagnostics Market, by Application, 2021 - 2033 (USD Million)
  • Table 29. France Personalized Diagnostics Market, by Testing Type, 2021 - 2033 (USD Million)
  • Table 30. France Personalized Diagnostics Market, by Technology, 2021 - 2033 (USD Million)
  • Table 31. France Personalized Diagnostics Market, by Application, 2021 - 2033 (USD Million)
  • Table 32. Italy Personalized Diagnostics Market, by Testing Type, 2021 - 2033 (USD Million)
  • Table 33. Italy Personalized Diagnostics Market, by Technology, 2021 - 2033 (USD Million)
  • Table 34. Italy Personalized Diagnostics Market, by Application, 2021 - 2033 (USD Million)
  • Table 35. Spain Personalized Diagnostics Market, by Testing Type, 2021 - 2033 (USD Million)
  • Table 36. Spain Personalized Diagnostics Market, by Technology, 2021 - 2033 (USD Million)
  • Table 37. Spain Personalized Diagnostics Market, by Application, 2021 - 2033 (USD Million)
  • Table 38. Denmark Personalized Diagnostics Market, by Testing Type, 2021 - 2033 (USD Million)
  • Table 39. Denmark Personalized Diagnostics Market, by Technology, 2021 - 2033 (USD Million)
  • Table 40. Denmark Personalized Diagnostics Market, by Application, 2021 - 2033 (USD Million)
  • Table 41. Sweden Personalized Diagnostics Market, by Testing Type, 2021 - 2033 (USD Million)
  • Table 42. Sweden Personalized Diagnostics Market, by Technology, 2021 - 2033 (USD Million)
  • Table 43. Sweden Personalized Diagnostics Market, by Application, 2021 - 2033 (USD Million)
  • Table 44. Norway Personalized Diagnostics Market, by Testing Type, 2021 - 2033 (USD Million)
  • Table 45. Norway Personalized Diagnostics Market, by Technology, 2021 - 2033 (USD Million)
  • Table 46. Norway Personalized Diagnostics Market, by Application, 2021 - 2033 (USD Million)
  • Table 47. Asia Pacific Personalized Diagnostics Market, by country, 2021 - 2033 (USD Million)
  • Table 48. Asia Pacific Personalized Diagnostics Market, by Testing Type, 2021 - 2033 (USD Million)
  • Table 49. Asia Pacific Personalized Diagnostics Market, by Technology, 2021 - 2033 (USD Million)
  • Table 50. Asia Pacific Personalized Diagnostics Market, by Application, 2021 - 2033 (USD Million)
  • Table 51. Japan Personalized Diagnostics Market, by Testing Type, 2021 - 2033 (USD Million)
  • Table 52. Japan Personalized Diagnostics Market, by Technology, 2021 - 2033 (USD Million)
  • Table 53. Japan Personalized Diagnostics Market, by Application, 2021 - 2033 (USD Million)
  • Table 54. China Personalized Diagnostics Market, by Testing Type, 2021 - 2033 (USD Million)
  • Table 55. China Personalized Diagnostics Market, by Technology, 2021 - 2033 (USD Million)
  • Table 56. China Personalized Diagnostics Market, by Application, 2021 - 2033 (USD Million)
  • Table 57. India Personalized Diagnostics Market, by Testing Type, 2021 - 2033 (USD Million)
  • Table 58. India Personalized Diagnostics Market, by Technology, 2021 - 2033 (USD Million)
  • Table 59. India Personalized Diagnostics Market, by Application, 2021 - 2033 (USD Million)
  • Table 60. Australia Personalized Diagnostics Market, by Testing Type, 2021 - 2033 (USD Million)
  • Table 61. Australia Personalized Diagnostics Market, by Technology, 2021 - 2033 (USD Million)
  • Table 62. Australia Personalized Diagnostics Market, by Application, 2021 - 2033 (USD Million)
  • Table 63. Thailand Personalized Diagnostics Market, by Testing Type, 2021 - 2033 (USD Million)
  • Table 64. Thailand Personalized Diagnostics Market, by Technology, 2021 - 2033 (USD Million)
  • Table 65. Thailand Personalized Diagnostics Market, by Application, 2021 - 2033 (USD Million)
  • Table 66. South Korea Personalized Diagnostics Market, by Testing Type, 2021 - 2033 (USD Million)
  • Table 67. South Korea Personalized Diagnostics Market, by Technology, 2021 - 2033 (USD Million)
  • Table 68. South Korea Personalized Diagnostics Market, by Application, 2021 - 2033 (USD Million)
  • Table 69. Latin America Personalized Diagnostics Market, by country, 2021 - 2033 (USD Million)
  • Table 70. Latin America Personalized Diagnostics Market, by Testing Type, 2021 - 2033 (USD Million)
  • Table 71. Latin America Personalized Diagnostics Market, by Technology, 2021 - 2033 (USD Million)
  • Table 72. Latin America Personalized Diagnostics Market, by Application, 2021 - 2033 (USD Million)
  • Table 73. Brazil Personalized Diagnostics Market, by Testing Type, 2021 - 2033 (USD Million)
  • Table 74. Brazil Personalized Diagnostics Market, by Technology, 2021 - 2033 (USD Million)
  • Table 75. Brazil Personalized Diagnostics Market, by Application, 2021 - 2033 (USD Million)
  • Table 76. Argentina Personalized Diagnostics Market, by Testing Type, 2021 - 2033 (USD Million)
  • Table 77. Argentina Personalized Diagnostics Market, by Technology, 2021 - 2033 (USD Million)
  • Table 78. Argentina Personalized Diagnostics Market, by Application, 2021 - 2033 (USD Million)
  • Table 79. Middle East & Africa Personalized Diagnostics Market, by country, 2021 - 2033 (USD Million)
  • Table 80. Middle East & Africa Personalized Diagnostics Market, by Testing Type, 2021 - 2033 (USD Million)
  • Table 81. Middle East & Africa Personalized Diagnostics Market, by Technology, 2021 - 2033 (USD Million)
  • Table 82. Middle East & Africa Personalized Diagnostics Market, by Application, 2021 - 2033 (USD Million)
  • Table 83. South Africa Personalized Diagnostics Market, by Testing Type, 2021 - 2033 (USD Million)
  • Table 84. South Africa Personalized Diagnostics Market, by Technology, 2021 - 2033 (USD Million)
  • Table 85. South Africa Personalized Diagnostics Market, by Application, 2021 - 2033 (USD Million)
  • Table 86. Saudi Arabia Personalized Diagnostics Market, by Testing Type, 2021 - 2033 (USD Million)
  • Table 87. Saudi Arabia Personalized Diagnostics Market, by Technology, 2021 - 2033 (USD Million)
  • Table 88. Saudi Arabia Personalized Diagnostics Market, by Application, 2021 - 2033 (USD Million)
  • Table 89. UAE Personalized Diagnostics Market, by Testing Type, 2021 - 2033 (USD Million)
  • Table 90. UAE Personalized Diagnostics Market, by Technology, 2021 - 2033 (USD Million)
  • Table 91. UAE Personalized Diagnostics Market, by Application, 2021 - 2033 (USD Million)
  • Table 92. Kuwait Personalized Diagnostics Market, by Testing Type, 2021 - 2033 (USD Million)
  • Table 93. Kuwait Personalized Diagnostics Market, by Technology, 2021 - 2033 (USD Million)
  • Table 94. Kuwait Personalized Diagnostics Market, by Application, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value chain-based sizing & forecasting
  • Fig. 6 Market formulation & validation
  • Fig. 7 Personalized Diagnostics Market segmentation
  • Fig. 8 Market snapshot, 2025
  • Fig. 9 Market trends & outlook
  • Fig. 10 Market driver relevance analysis (current & future impact)
  • Fig. 11 Market restraint relevance analysis (current & future impact)
  • Fig. 12 SWOT analysis, by factor (political & legal, economic, and technological)
  • Fig. 13 Porter's five forces analysis
  • Fig. 14 Market penetration & growth prospect mapping, 2025
  • Fig. 15 Global Personalized Diagnostics Market: Testing Type movement analysis
  • Fig. 16 Microbiome Testing market estimates and forecast, 2021 - 2033
  • Fig. 17 Metabolic Health Testing market estimates and forecast, 2021 - 2033
  • Fig. 18 Micronutrient & Deficiency Testing market estimates and forecast, 2021 - 2033
  • Fig. 19 Food Sensitivity & Intolerance Testing market estimates and forecast, 2021 - 2033
  • Fig. 20 Hormone Health Testing market estimates and forecast, 2021 - 2033
  • Fig. 21 Preventive Wellness & Longevity Testing market estimates and forecast, 2021 - 2033
  • Fig. 22 Epigenetic Age Testing market estimates and forecast, 2021 - 2033
  • Fig. 23 Telomere Length Analysis market estimates and forecast, 2021 - 2033
  • Fig. 24 Proteomics-based Aging Biomarkers market estimates and forecast, 2021 - 2033
  • Fig. 25 Others market estimates and forecast, 2021 - 2033
  • Fig. 26 Others market estimates and forecast, 2021 - 2033
  • Fig. 27 Global Personalized Diagnostics Market: Technology movement analysis
  • Fig. 28 Next-Generation Sequencing (NGS) market estimates and forecast, 2021 - 2033
  • Fig. 29 Immunoassays market estimates and forecast, 2021 - 2033
  • Fig. 30 Polymerase Chain Reaction (PCR) market estimates and forecast, 2021 - 2033
  • Fig. 31 Mass Spectrometry market estimates and forecast, 2021 - 2033
  • Fig. 32 Microarray Technology market estimates and forecast, 2021 - 2033
  • Fig. 33 Others Market, 2021 - 2033 (USD Million)
  • Fig. 34 Global Personalized Diagnostics Market: Application movement analysis
  • Fig. 35 Personalized Nutrition market estimates and forecast, 2021 - 2033
  • Fig. 36 Preventive Health Screening market estimates and forecast, 2021 - 2033
  • Fig. 37 Weight Management market estimates and forecast, 2021 - 2033
  • Fig. 38 Healthy Aging & Longevity market estimates and forecast, 2021 - 2033
  • Fig. 39 Chronic Disease Risk Assessment market estimates and forecast, 2021 - 2033
  • Fig. 40 Gut Health & Microbiome Analysis market estimates and forecast, 2021 - 2033
  • Fig. 41 Fitness & Lifestyle Optimization market estimates and forecast, 2021 - 2033
  • Fig. 42 Pharmacogenomics market estimates and forecast, 2021 - 2033
  • Fig. 43 Others market estimates and forecast, 2021 - 2033
  • Fig. 44 Global Personalized Diagnostics Market: End Use movement analysis
  • Fig. 45 Direct-to-Consumer (DTC) market estimates and forecast, 2021 - 2033
  • Fig. 46 Diagnostic Laboratories market estimates and forecast, 2021 - 2033
  • Fig. 47 Wellness & Nutrition Companies market estimates and forecast, 2021 - 2033
  • Fig. 48 Hospitals & Clinics market estimates and forecast, 2021 - 2033
  • Fig. 49 Others market estimates and forecast, 2021 - 2033
  • Fig. 50 Regional marketplace: Key takeaways
  • Fig. 51 Regional outlook, 2025 & 2033
  • Fig. 52 Global Personalized Diagnostics Market: Region movement analysis
  • Fig. 53 North America Personalized Diagnostics Market, 2021 - 2033 (USD Million)
  • Fig. 54 U.S. Personalized Diagnostics Market, 2021 - 2033 (USD Million)
  • Fig. 55 Canada Personalized Diagnostics Market, 2021 - 2033 (USD Million)
  • Fig. 56 Mexico Personalized Diagnostics Market, 2021 - 2033 (USD Million)
  • Fig. 57 Europe Personalized Diagnostics Market, 2021 - 2033 (USD Million)
  • Fig. 58 Germany Personalized Diagnostics Market, 2021 - 2033 (USD Million)
  • Fig. 59 UK Personalized Diagnostics Market, 2021 - 2033 (USD Million)
  • Fig. 60 France Personalized Diagnostics Market, 2021 - 2033 (USD Million)
  • Fig. 61 Italy Personalized Diagnostics Market, 2021 - 2033 (USD Million)
  • Fig. 62 Spain Personalized Diagnostics Market, 2021 - 2033 (USD Million)
  • Fig. 63 Denmark Personalized Diagnostics Market, 2021 - 2033 (USD Million)
  • Fig. 64 Sweden Personalized Diagnostics Market, 2021 - 2033 (USD Million)
  • Fig. 65 Norway Personalized Diagnostics Market, 2021 - 2033 (USD Million)
  • Fig. 66 Asia Pacific Personalized Diagnostics Market, 2021 - 2033 (USD Million)
  • Fig. 67 Japan Personalized Diagnostics Market, 2021 - 2033 (USD Million)
  • Fig. 68 China Personalized Diagnostics Market, 2021 - 2033 (USD Million)
  • Fig. 69 India Personalized Diagnostics Market, 2021 - 2033 (USD Million)
  • Fig. 70 Australia Personalized Diagnostics Market, 2021 - 2033 (USD Million)
  • Fig. 71 South Korea Personalized Diagnostics Market, 2021 - 2033 (USD Million)
  • Fig. 72 Thailand Personalized Diagnostics Market, 2021 - 2033 (USD Million)
  • Fig. 73 Latin America Personalized Diagnostics Market, 2021 - 2033 (USD Million)
  • Fig. 74 Brazil Personalized Diagnostics Market, 2021 - 2033 (USD Million)
  • Fig. 75 Argentina Personalized Diagnostics Market, 2021 - 2033 (USD Million)
  • Fig. 76 Middle East and Africa Personalized Diagnostics Market, 2021 - 2033 (USD Million)
  • Fig. 77 South Africa Personalized Diagnostics Market, 2021 - 2033 (USD Million)
  • Fig. 78 Saudi Arabia Personalized Diagnostics Market, 2021 - 2033 (USD Million)
  • Fig. 79 UAE Personalized Diagnostics Market, 2021 - 2033 (USD Million)
  • Fig. 80 Kuwait Personalized Diagnostics Market, 2021 - 2033 (USD Million)